The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells
暂无分享,去创建一个
Harald Schmidt | Brigitte Lankat-Buttgereit | Rüdiger Göke | Barbara Lenschen | R. Göke | B. Lankat-Buttgereit | H. Schmidt | Barbara Lenschen
[1] E. Kremmer,et al. dUTPase in human neoplastic cells as a potential target for therapeutic intervention. , 2001, Current protein & peptide science.
[2] H. Kizaki,et al. Cloning of the TIS gene suppressed by topoisomerase inhibitors. , 1998, Gene.
[3] Jennifer L. Knies,et al. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation , 2003, Oncogene.
[4] Birgit Samans,et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1 , 2004 .
[5] N. Sonenberg,et al. The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.
[6] E. Kremmer,et al. Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours , 1999, International journal of cancer.
[7] C. Fujiyama,et al. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti‐H731 antibody , 1999, Pathology international.
[8] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[9] H. Mo,et al. Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention , 2004, Experimental biology and medicine.
[10] T. Lawrence,et al. Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate. , 1993, Cancer research.
[11] R. Ladner,et al. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. , 2004, Molecular pharmacology.
[12] K. Ohyashiki,et al. Transcriptional profiling of Epstein–Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection , 2006, British Journal of Cancer.
[13] N. Colburn,et al. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. , 2005, Cancer research.
[14] R. Arnold,et al. Programmed Cell Death Protein 4 (PDCD4) Acts As a Tumor Suppressor in Neuroendocrine Tumor Cells , 2004, Annals of the New York Academy of Sciences.
[15] S. Carr,et al. Identification of a Consensus Cyclin-dependent Kinase Phosphorylation Site Unique to the Nuclear Form of Human Deoxyuridine Triphosphate Nucleotidohydrolase (*) , 1996, The Journal of Biological Chemistry.
[16] N. Colburn,et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] N. Colburn,et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation , 2001, Oncogene.
[18] W. Park,et al. Up-regulation of PDCD4 in senescent human diploid fibroblasts. , 2002, Biochemical and biophysical research communications.
[19] N. Colburn,et al. Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion , 2006, Molecular and Cellular Biology.
[20] H. Samuels,et al. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis , 2004, Oncogene.
[21] A. Hasilik,et al. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II , 2004, Molecular and Cellular Endocrinology.
[22] B. Samans,et al. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). , 2004, American journal of physiology. Cell physiology.
[23] H. Kizaki,et al. Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. , 1996, Biochemical and biophysical research communications.
[24] Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death , 1996 .
[25] A. Palmieri,et al. Potential Markers of Tongue Tumor Progression Selected by cDNA Micro Array , 2005, International journal of immunopathology and pharmacology.
[26] K. Klempnauer,et al. Targeted disruption of c-myb in the chicken pre B-cell line DT40 , 2002, Oncogene.
[27] L. Azzoni,et al. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. , 1998, Journal of immunology.
[28] K. Klempnauer,et al. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA , 2003, Oncogene.
[29] N. Colburn,et al. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. , 2004, Molecular cancer therapeutics.
[30] A. Hartl,et al. Particulate nitrocellulose as a solid phase for protein immobilization in immuno-affinity chromatography. , 1993, Journal of immunological methods.
[31] T. Honjo,et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. , 1995, Gene.
[32] H. Zhang,et al. Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.
[33] K. Klempnauer,et al. The chicken Pdcd4 gene is regulated by v-Myb , 2001, Oncogene.
[34] R. Carmody,et al. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. , 2002, Biochemical and biophysical research communications.
[35] Iver Petersen,et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis , 2003, The Journal of pathology.